Clinical and statistical characteristics of primary open-angle glaucoma in patients with age-related cataract in the Khabarovsk territory-Reference-Cited by-同舟云学术

Clinical and statistical characteristics of primary open-angle glaucoma in patients with age-related cataract in the Khabarovsk territory

Published:2024-06-26 Issue:2 Volume:23 Page:50-55
ISSN:2311-6862
Container-title:National Journal glaucoma
language:
Short-container-title:Glaucoma

Author:

Vasiliev A. V.¹^ORCID,Kolenko O. V.²^ORCID,Samokhvalov N. V.¹^ORCID

Affiliation:

1. Khabarovsk branch of S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery"

2. Khabarovsk branch of S.N. Fedorov National Medical Research Center "MNTK "Eye Microsurgery"; Postgraduate Institute for Public Health Specialists; Far-Eastern State Medical University

Abstract

PURPOSE. To investigate the clinical and statistical characteristics of primary open-angle glaucoma (POAG) in patients with age-related cataract (ARC) in the Khabarovsk territory of the Russian Federation.METHODS. The study examined a total of 231 patients (462 eyes), including 113 men and 118 women aged from 55 to 88 years (average 71 years) with ARC and POAG of different stages.RESULTS. Stage II glaucoma was detected in the maximum number of eyes with ARC, while stages I and III were less common. In 31 eyes (6.7%), there was a terminal stage of POAG. Moreover, only 10 eyes had previously been operated on for glaucoma. The most widely used drugs in patients with stages I and II POAG are prostaglandin analogues, while in stages III and IV — various combinations of hypotensive drugs.CONCLUSION. Among all studied eyes, 320 (69.2%) (except for stage IV) did not have target intraocular pressure indicators established by the Federal Clinical Recommendations. In regard to the used drug therapy, it should be noted that in 183 eyes (36.9%) two or more hypotensive drugs were prescribed.

Publisher

Research Institute of Eye Diseases

Reference17 articles.

1. Isaiev O., Serdiuk V., Ustymenko S. Prevalence and epidemiology of primary open-angle glaucoma. Ophthalmology. Eastern Europe 2021; 11(3):343-354. https://doi.org/10.34883/PI.2021.11.3.033

2. World report on vision. Geneva: World Health Organization. Available at: https://www.who.int/health-topics/blindness-and-vision-loss#tab=tab_1 Accessed October 20, 2023

3. Burganova A.M. The prevalence of glaucoma in the conditions of large industrial city. Public health and health care 2017; 56(4):33-36.

4. Sakhnov S.N. Quality of life as a criterion of efficiency of treatment of glaucoma patients. Bulletin of Semashko National Research Institute of Public Health 2018; (2):51-57.

5. Antonov A.A., Kozlova I.V., Vitkov A.A. Maximum medical therapy for glaucoma – what is in our arsenal? National journal glaucoma 2020; 19(2):51-58. https://doi.org/10.25700/NJG.2020.02.06